• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

配备可连接侧链的α4β1整合素α/β杂合肽配体的设计,用于微结构材料的化学选择性生物功能化。

Design of α/β-Hybrid Peptide Ligands of α4β1 Integrin Equipped with a Linkable Side Chain for Chemoselective Biofunctionalization of Microstructured Materials.

作者信息

Anselmi Michele, Baiula Monica, Santino Federica, Zhao Junwei, Spampinato Santi, Calonghi Natalia, Gentilucci Luca

机构信息

Department of Chemistry "G. Ciamician", University of Bologna, Via Selmi 2, 40126 Bologna, Italy.

Department of Pharmacy and Biotechnology, University of Bologna, Via Irnerio 48, 40126 Bologna, Italy.

出版信息

Biomedicines. 2021 Nov 21;9(11):1737. doi: 10.3390/biomedicines9111737.

DOI:10.3390/biomedicines9111737
PMID:34829965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8615975/
Abstract

Arg-Gly-Asp (RGD)-binding integrins, e.g., αvβ3, αvβ1, αvβ5 integrins, are currently regarded as privileged targets for the delivery of diagnostic and theranostic agents, especially in cancer treatment. In contrast, scarce attention has been paid so far to the diagnostic opportunities promised by integrins that recognize other peptide motifs. In particular, α4β1 integrin is involved in inflammatory, allergic, and autoimmune diseases, therefore, it represents an interesting therapeutic target. Aiming at obtaining simple, highly stable ligands of α4β1 integrin, we designed hybrid α/β peptidomimetics carrying linkable side chains for the expedient functionalization of biomaterials, nano- and microparticles. We identified the prototypic ligands MPUPA-()-isoAsp(NHPr)-Gly-OH () and MPUPA-Dap(Ac)-Gly-OH () (MPUPA, methylphenylureaphenylacetic acid; Dap, 2,3-diamino propionic acid). Modification of and by introduction of flexible linkers at isoAsp or Dap gave and , respectively, which allowed for coating with monolayers (ML) of flat zeolite crystals. The resulting peptide-zeolite MLs were able to capture selectively α4β1 integrin-expressing cells. In perspective, the α4β1 integrin ligands identified in this study can find applications for preparing biofunctionalized surfaces and diagnostic devices to control the progression of α4β1 integrin-correlated diseases.

摘要

精氨酸-甘氨酸-天冬氨酸(RGD)结合整合素,例如αvβ3、αvβ1、αvβ5整合素,目前被视为诊断和治疗诊断剂递送的优先靶点,尤其是在癌症治疗中。相比之下,迄今为止,对于识别其他肽基序的整合素所带来的诊断机会关注较少。特别是,α4β1整合素参与炎症、过敏和自身免疫性疾病,因此,它是一个有趣的治疗靶点。为了获得简单、高度稳定的α4β1整合素配体,我们设计了带有可连接侧链的α/β肽模拟物,以便对生物材料、纳米颗粒和微粒进行便捷的功能化修饰。我们鉴定出了原型配体MPUPA-()-异天冬氨酸(NHPr)-甘氨酸-OH ()和MPUPA-二氨基丙酸(Ac)-甘氨酸-OH ()(MPUPA,甲基苯基脲苯基乙酸;Dap,2,3-二氨基丙酸)。通过在异天冬氨酸或二氨基丙酸处引入柔性接头对 和 进行修饰,分别得到了 和 ,它们能够用扁平沸石晶体的单层(ML)进行包被。所得的肽-沸石ML能够选择性地捕获表达α4β1整合素的细胞。从长远来看,本研究中鉴定出的α4β1整合素配体可用于制备生物功能化表面和诊断设备,以控制与α4β1整合素相关疾病的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/a83e475f2860/biomedicines-09-01737-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/ea136852ce3a/biomedicines-09-01737-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/05e04985982d/biomedicines-09-01737-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/870f9a4bd318/biomedicines-09-01737-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/1955dabba5a7/biomedicines-09-01737-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/324440f689f0/biomedicines-09-01737-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/901fdf7f1c3d/biomedicines-09-01737-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/c02b8a149974/biomedicines-09-01737-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/97243343f4e3/biomedicines-09-01737-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/36e50e5737c5/biomedicines-09-01737-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/e926a999b5e9/biomedicines-09-01737-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/94bc22f6d8f9/biomedicines-09-01737-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/d789ee8a0b8e/biomedicines-09-01737-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/8c77331b30bb/biomedicines-09-01737-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/a83e475f2860/biomedicines-09-01737-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/ea136852ce3a/biomedicines-09-01737-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/05e04985982d/biomedicines-09-01737-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/870f9a4bd318/biomedicines-09-01737-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/1955dabba5a7/biomedicines-09-01737-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/324440f689f0/biomedicines-09-01737-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/901fdf7f1c3d/biomedicines-09-01737-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/c02b8a149974/biomedicines-09-01737-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/97243343f4e3/biomedicines-09-01737-sch006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/36e50e5737c5/biomedicines-09-01737-sch007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/e926a999b5e9/biomedicines-09-01737-sch008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/94bc22f6d8f9/biomedicines-09-01737-sch009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/d789ee8a0b8e/biomedicines-09-01737-sch010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/8c77331b30bb/biomedicines-09-01737-sch011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efe2/8615975/a83e475f2860/biomedicines-09-01737-g003.jpg

相似文献

1
Design of α/β-Hybrid Peptide Ligands of α4β1 Integrin Equipped with a Linkable Side Chain for Chemoselective Biofunctionalization of Microstructured Materials.配备可连接侧链的α4β1整合素α/β杂合肽配体的设计,用于微结构材料的化学选择性生物功能化。
Biomedicines. 2021 Nov 21;9(11):1737. doi: 10.3390/biomedicines9111737.
2
Synthesis and assay of retro-α4β1 integrin-targeting motifs.反向α4β1 整联蛋白靶向基序的合成与检测。
Eur J Med Chem. 2014 Feb 12;73:225-32. doi: 10.1016/j.ejmech.2013.12.009. Epub 2013 Dec 19.
3
Selective detection of α4β1 integrin (VLA-4)-expressing cells using peptide-functionalized nanostructured materials mimicking endothelial surfaces adjacent to inflammatory sites.使用模拟炎症部位附近内皮表面的肽功能化纳米结构材料对表达α4β1整合素(VLA-4)的细胞进行选择性检测。
Biopolymers. 2017 Nov 27. doi: 10.1002/bip.23081.
4
The Design of Potent, Selective and Drug-Like RGD αvβ1 Small-Molecule Inhibitors Derived from non-RGD α4β1 Antagonists.强效、选择性且类药性的 RGDαvβ1 小分子抑制剂的设计,源自非 RGDα4β1 拮抗剂。
ChemMedChem. 2019 Jul 17;14(14):1315-1320. doi: 10.1002/cmdc.201900359. Epub 2019 Jul 1.
5
New 4-Aminoproline-Based Small Molecule Cyclopeptidomimetics as Potential Modulators of αβ Integrin.新型基于 4-氨基脯氨酸的小分子环肽拟似物作为 αβ 整合素的潜在调节剂。
Molecules. 2021 Oct 7;26(19):6066. doi: 10.3390/molecules26196066.
6
5-aminomethyloxazolidine-2,4-dione hybrid α/β-dipeptide scaffolds as inductors of constrained conformations: Applications to the synthesis of integrin antagonists.5-氨甲基恶唑烷-2,4-二酮杂化α/β-二肽支架作为受限构象的诱导剂:在整合素拮抗剂合成中的应用。
Biopolymers. 2015 Sep;104(5):636-49. doi: 10.1002/bip.22704.
7
Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.抑制过敏性气道反应的整合素α4β1选择性紧密结合抑制剂。
J Med Chem. 1999 Mar 11;42(5):920-34. doi: 10.1021/jm980673g.
8
Rotaviruses interact with alpha4beta7 and alpha4beta1 integrins by binding the same integrin domains as natural ligands.轮状病毒通过与天然配体结合相同的整合素结构域来与α4β7和α4β1整合素相互作用。
J Gen Virol. 2005 Dec;86(Pt 12):3397-3408. doi: 10.1099/vir.0.81102-0.
9
A molecular toolkit for the functionalization of titanium-based biomaterials that selectively control integrin-mediated cell adhesion.用于钛基生物材料功能化的分子工具包,可选择性控制整合素介导的细胞黏附。
Chemistry. 2013 Jul 8;19(28):9218-23. doi: 10.1002/chem.201301478. Epub 2013 Jun 6.
10
Exploring the Role of RGD-Recognizing Integrins in Cancer.探索RGD识别整合素在癌症中的作用。
Cancers (Basel). 2017 Sep 4;9(9):116. doi: 10.3390/cancers9090116.

引用本文的文献

1
Conjecturing about Small-Molecule Agonists and Antagonists of α4β1 Integrin: From Mechanistic Insight to Potential Therapeutic Applications.α4β1整合素小分子激动剂与拮抗剂的推测:从机制洞察到潜在治疗应用
Biomedicines. 2024 Jan 30;12(2):316. doi: 10.3390/biomedicines12020316.
2
Design, Pharmacological Characterization, and Molecular Docking of Minimalist Peptidomimetic Antagonists of αβ Integrin.设计、药理学表征和最小肽模拟物 αβ 整合素拮抗剂的分子对接。
Int J Mol Sci. 2023 May 31;24(11):9588. doi: 10.3390/ijms24119588.
3
Design and Pharmacological Characterization of αβ Integrin Cyclopeptide Agonists: Computational Investigation of Ligand Determinants for Agonism versus Antagonism.

本文引用的文献

1
Leukocyte Integrin Antagonists as a Novel Option to Treat Dry Age-Related Macular Degeneration.白细胞整合素拮抗剂作为治疗干性年龄相关性黄斑变性的新选择。
Front Pharmacol. 2021 Jan 29;11:617836. doi: 10.3389/fphar.2020.617836. eCollection 2020.
2
Linker Hydrophilicity Modulates the Anticancer Activity of RGD-Cryptophycin Conjugates.连接亲水基团调节 RGD-隐色菌素缀合物的抗癌活性。
Chemistry. 2021 Jan 13;27(3):1015-1022. doi: 10.1002/chem.202003471. Epub 2020 Dec 8.
3
Integrin-Targeting Peptides for the Design of Functional Cell-Responsive Biomaterials.
αβ 整合素环肽激动剂的设计与药理学特性:激动剂与拮抗剂配体决定因素的计算研究。
J Med Chem. 2023 Apr 13;66(7):5021-5040. doi: 10.1021/acs.jmedchem.2c02098. Epub 2023 Mar 28.
4
Characterization of Integrin Molecular Tension of Human Breast Cancer Cells on Anisotropic Nanopatterns.人乳腺癌细胞在各向异性纳米图案上的整合素分子张力表征
Front Mol Biosci. 2022 Jun 9;9:825970. doi: 10.3389/fmolb.2022.825970. eCollection 2022.
用于设计功能性细胞响应生物材料的整合素靶向肽
Biomedicines. 2020 Aug 25;8(9):307. doi: 10.3390/biomedicines8090307.
4
Integrin-Targeting Dye-Doped PEG-Shell/Silica-Core Nanoparticles Mimicking the Proapoptotic Smac/DIABLO Protein.模拟促凋亡蛋白Smac/DIABLO的靶向整合素的染料掺杂聚乙二醇壳/二氧化硅核纳米颗粒
Nanomaterials (Basel). 2020 Jun 21;10(6):1211. doi: 10.3390/nano10061211.
5
Could Dissecting the Molecular Framework of β-Lactam Integrin Ligands Enhance Selectivity?β-内酰胺整合素配体的分子结构剖析能否提高选择性?
J Med Chem. 2019 Nov 27;62(22):10156-10166. doi: 10.1021/acs.jmedchem.9b01000. Epub 2019 Nov 12.
6
Novel Ligands Targeting αβ Integrin: Therapeutic Applications and Perspectives.靶向αβ整合素的新型配体:治疗应用与展望
Front Chem. 2019 Jul 9;7:489. doi: 10.3389/fchem.2019.00489. eCollection 2019.
7
Are Integrins Still Practicable Targets for Anti-Cancer Therapy?整合素仍是抗癌治疗的可行靶点吗?
Cancers (Basel). 2019 Jul 12;11(7):978. doi: 10.3390/cancers11070978.
8
DS-70, a novel and potent α integrin antagonist, is an effective treatment for experimental allergic conjunctivitis in guinea pigs.DS-70,一种新型强效的 α 整合素拮抗剂,对豚鼠实验性变应性结膜炎有治疗作用。
Br J Pharmacol. 2018 Oct;175(20):3891-3910. doi: 10.1111/bph.14458. Epub 2018 Sep 17.
9
Achieving Controlled Biomolecule-Biomaterial Conjugation.实现可控生物分子-生物材料偶联。
Chem Rev. 2018 Aug 22;118(16):7702-7743. doi: 10.1021/acs.chemrev.8b00253. Epub 2018 Jul 24.
10
Smart biomaterials: Surfaces functionalized with proteolytically stable osteoblast-adhesive peptides.智能生物材料:用蛋白水解稳定的成骨细胞黏附肽功能化的表面。
Bioact Mater. 2017 May 18;2(3):121-130. doi: 10.1016/j.bioactmat.2017.05.004. eCollection 2017 Sep.